NCT04893434 2026-02-20
Novel Imaging Technique to Assess Gynecologic Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Recruiting
Clinical Trials
15 trialsNCT07415018 2026-02-17
Optimizing Contrast Dose and Scanning Parameters for Detection of Leptomeningeal Disease
M.D. Anderson Cancer Center
Phase NA Not yet recruiting
NCT04373564 2026-01-22
ODYSSEY
Guerbet
Phase 4 Recruiting
NCT04910425 2025-10-21
PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer
Northwestern University
Phase 2 Withdrawn
NCT04132843 2022-11-21
Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions
M.D. Anderson Cancer Center
Phase NA Completed
NCT03404648 2021-02-08
Staging Prostate Cancer With Hybrid C11-Choline PET/MR and mpMRI
Mayo Clinic
Phase 3 Completed
NCT02796729 2019-01-28
CEST- Glucose Enhanced MRI for Metastatic Brain Tumours
British Columbia Cancer Agency
Phase 2 Terminated
NCT00522951 2017-08-28
SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study
Bayer
Phase 3 Completed
NCT02967380 2017-03-27
Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases
University of Southern California
Phase NA Terminated
NCT01995240 2017-03-20
REMP
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase NA Completed
NCT02294838 2016-11-28
SPIT
British Columbia Cancer Agency
Phase NA Unknown
NCT01050829 2014-12-30
Gadobutrol Magnevist-controlled Body Study
Bayer
Phase 3 Completed
NCT01067976 2014-11-11
Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI
Bayer
Phase 3 Completed
NCT01104584 2014-11-11
GEMMA 2
Bayer
Phase 3 Completed
NCT02036008 2014-01-14
Gadofosveset Trisodium (Ablavar, Gdfos) in Distinguishing Hemangiomas and Metastases: A Prospective Trial
Sunnybrook Health Sciences Centre
Phase NA Unknown